Support PenkeMesoblast Ltd - Trending symbols
Latest News of Mesoblast Ltd
| Date | Title | Read |
|---|---|---|
| 2025-11-21 00:32 | Mesoblast and BMT CTN to Initiate Pivotal Trial of Ryoncil® as Part of First-Line Regimen in Adults with Severe Acute GVHD Refractory to Steroids | Read |
Trends
| 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Profit | -120,199 | 38,258 | -81,941 | 9,121 | -72,820 | 18,816 | -54,004 | 72,536 | 18,532 | |
| Tax Provision | -1,258 | 891 | -367 | 41 | -326 | 32 | -293 | 800 | 507 | |
| Income Tax Expense | -14,146 | 12,915 | -1,231 | 871 | -359 | 41 | -319 | 606 | 287 | |
| Other Stockholders Equity | -755,295 | -19,370 | -774,665 | 134,009 | -640,655 | -2,892 | -643,548 | 643,548 | 0 | |
| Other Current Liabilities | 46,677 | -16,766 | 29,912 | -26,419 | 3,493 | 5,181 | 8,675 | -73,248 | -64,573 | |
| Total Other Income Expense Net | 2,122 | 26,616 | 28,739 | -19,091 | 9,647 | 317 | 9,964 | -27,405 | -17,441 | |
| Cash And Equivalents | 13 | 85,489 | 85,502 | -85,095 | 407 | -4 | 403 | -405 | -2 |
Comments
How you think about this?